Last reviewed · How we verify
NCT05314790: TIAMO
Management of Patients With Diagnosis of Hypothyroidism, as Hospitalized and as Outpatients, in Internal Medicine Units: Observational Study Before & After Educational Programme
trial testing intervening Educational Program in Hypothyroidism in 1,200 participants. Completed in 1 January 2019.
1 January 2018
Quick facts
| Lead sponsor | Fadoi Foundation, Italy |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,200 |
| Start date | 1 June 2016 |
| Primary completion | 1 January 2018 |
| Estimated completion | 1 January 2019 |
| Sites | 20 locations across Italy |
Drugs / interventions tested
- intervening Educational Program
Conditions studied
- Hypothyroidism — all drugs for Hypothyroidism →
Sponsor
Fadoi Foundation, Italy
Who can join
18 and older, any sex, with Hypothyroidism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is still limited knowledge regarding the clinical profile and appropriateness of treatment in patients with hypothyroidism hospitalized in Internal Medicine (IM) Departments in Italy. The aim of this study is to evaluate: 1) the characteristics of patients and possible deviations from national and international clinical practice recommendations (CPRs) in evidence-based guidelines (EBGs); 2) the improvement of patient management by means of a standardized educational programme (EP). Methods: A nationwide multicentre study, comprising two replications of a retrospective survey (phases 1 and 3) with an intervening EP (phase 2) in half of the centres and no EP in the other half, was conducted. The EP was based on outreach visits. Centres were assigned to the two arms of the study, labelled the training group (TG) and control group (CG) respectively, by cluster randomization.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Management of Hypothyroidism in Internal Medicine: Patient Profile and Effects of an Educational Programme in the Cluster-Randomized FADOI TIAMO Study.
Brancato D, Biondi B, Attardo TM, Fierro A, et al · · 2022 · PMID 35769080 · DOI 10.3389/fendo.2022.839300
Verify or expand the search:
- PubMed search for NCT05314790
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypothyroidism
Currently open trials in the same condition.
- NCT07060118 — Gluten Free Diet in Hashimoto's Hypothyroidism · NA · recruiting
- NCT06757712 — Periodization Resistance Training on Quality of Life in Females With Hypothyroidism · NA · recruiting
- NCT06731764 — Novel Approaches to the Treatment of Hypothyroidism · Phase 2, PHASE3 · recruiting
- NCT06826248 — Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal I · EARLY_PHASE1 · active not recruiting
- NCT07421869 — SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial · NA · recruiting
Other Fadoi Foundation, Italy trials
Trials by the same sponsor.
- NCT05239988 — Observational Study in COVID-19 Patients Treated With Remdesivir · completed
- NCT05247931 — Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study · unknown
- NCT04257422 — Intentional Rounding in Internal Medicine · NA · terminated
- NCT06293768 — Continuous Wireless Monitoring for Patients in the Internal Medicine UOC. Randomized Controlled Trial (GreenLineH-T) · NA · completed
- NCT04589533 — MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS HOSPITALIZED IN INTERNAL MEDICINE UNITS (MINDER Study) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05314790 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fadoi Foundation, Italy
- Last refreshed: 6 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05314790.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing